Trial intelligence / Profile preview

Lymphofluoroscopy to validate manual drainage techniques in upper limb lymphedema

2013-001360-36Phase 2Completed

Sponsor
Unité de Recherche en Lymphologie
Start
Aug 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of indocyanine green in upper extremity lymphedema (UEL) (2 arms), sponsored by Unité de Recherche en Lymphologie. Primary endpoint: Visualization of superficial lymphatic network in lymphedema patients. Started Aug 2013; status: completed.

02

Drugs

indocyanine green
03

Conditions

upper extremity lymphedema (UEL)

Beyond the preview

Go deeper on 2013-001360-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-001360-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call